Balyasny Asset Management »

Cytokinetics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $68M 816k 83.49
2023-09-30 $36M 1.2M 29.46
2023-06-30 $35M 1.1M 32.62
2023-03-31 $34M 952k 35.19
2022-12-31 $40M 881k 45.82
2022-09-30 $14M 283k 48.21
2022-06-30 $7.4M 189k 39.29
2021-12-31 $452k 9.9k 45.61
2021-09-30 $1.3M 37k 35.73
2020-09-30 $3.6M 165k 21.65
2017-12-31 $162k 20k 8.15
2017-09-30 $12M 842k 14.50
2017-06-30 $7.6M 632k 12.10
2017-03-31 $6.5M 508k 12.85
2016-12-31 $4.0M 326k 12.15
2016-03-31 $1.2M 177k 7.05
2015-12-31 $2.4M 232k 10.46